Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Langdon

Showing results (51-60 of 83) with videos related to

Pageof 9
Sort By:
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|October 29, 2013
Dipeptidyl peptidase-4 inhibition in patients with type 2 diabetes treated with saxagliptin, sitagliptin, or vildagliptinDaniel A Tatosian, Ying Guo, Andrea K Schaeffer, et al.
European Journal of Pharmacology|May 15, 2010
A small-molecule glucokinase activator lowers blood glucose in the sulfonylurea-desensitized ratSumika Ohyama, Hiroki Takano, Tomoharu Iino, et al.
Journal of Clinical Microbiology|June 1, 1987
Evidence for depressed humoral immunity to Pneumocystis carinii in homosexual males, commercial plasma donors, and patients with acquired immunodeficiency syndromeL L Pifer, H B Niell, S B Langdon, et al.
ACS Applied Materials & Interfaces|January 23, 2015
Single-molecule resolution of protein dynamics on polymeric membrane surfaces: the roles of spatial and population heterogeneityBlake B Langdon, Roya B Mirhossaini, Joshua N Mabry, et al.
Physical Review Letters|June 29, 2006
Creation of hot radiation environments in laser-driven targetsD E Hinkel, M B Schneider, B K Young, et al.
Journal of Integrative Bioinformatics|February 6, 2010
Widespread existence of uncorrelated probe intensities from within the same probeset on Affymetrix GeneChipsOlivia Sanchez-Graillet, Joanna Rowsell, William B Langdon, et al.
Current Medical Research and Opinion|January 16, 2008
Efficacy and safety of sitagliptin added to ongoing metformin therapy in patients with type 2 diabetesItamar Raz, Yu Chen, Mei Wu, et al.
European Journal of Clinical Pharmacology|April 25, 2012
Pharmacokinetics of the novel PAR-1 antagonist vorapaxar in patients with hepatic impairmentPaul Statkevich, Teddy Kosoglou, Richard A Preston, et al.
Biochemical Society Transactions|May 17, 2008
The use of Affymetrix GeneChips as a tool for studying alternative forms of RNAAndrew P Harrison, Joanna Rowsell, Renata da Silva Camargo, et al.
Diabetes Research and Clinical Practice|December 23, 2008
Efficacy and safety of sitagliptin in the treatment of patients with type 2 diabetes in China, India, and KoreaViswanathan Mohan, Wenying Yang, Ho-Young Son, et al.
Pageof 9

Showing results (51-60 of 83) with videos related to

Sort By:
Pageof 9
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|October 29, 2013
Dipeptidyl peptidase-4 inhibition in patients with type 2 diabetes treated with saxagliptin, sitagliptin, or vildagliptinDaniel A Tatosian, Ying Guo, Andrea K Schaeffer, et al.
European Journal of Pharmacology|May 15, 2010
A small-molecule glucokinase activator lowers blood glucose in the sulfonylurea-desensitized ratSumika Ohyama, Hiroki Takano, Tomoharu Iino, et al.
Journal of Clinical Microbiology|June 1, 1987
Evidence for depressed humoral immunity to Pneumocystis carinii in homosexual males, commercial plasma donors, and patients with acquired immunodeficiency syndromeL L Pifer, H B Niell, S B Langdon, et al.
ACS Applied Materials & Interfaces|January 23, 2015
Single-molecule resolution of protein dynamics on polymeric membrane surfaces: the roles of spatial and population heterogeneityBlake B Langdon, Roya B Mirhossaini, Joshua N Mabry, et al.
Physical Review Letters|June 29, 2006
Creation of hot radiation environments in laser-driven targetsD E Hinkel, M B Schneider, B K Young, et al.
Journal of Integrative Bioinformatics|February 6, 2010
Widespread existence of uncorrelated probe intensities from within the same probeset on Affymetrix GeneChipsOlivia Sanchez-Graillet, Joanna Rowsell, William B Langdon, et al.
Current Medical Research and Opinion|January 16, 2008
Efficacy and safety of sitagliptin added to ongoing metformin therapy in patients with type 2 diabetesItamar Raz, Yu Chen, Mei Wu, et al.
European Journal of Clinical Pharmacology|April 25, 2012
Pharmacokinetics of the novel PAR-1 antagonist vorapaxar in patients with hepatic impairmentPaul Statkevich, Teddy Kosoglou, Richard A Preston, et al.
Biochemical Society Transactions|May 17, 2008
The use of Affymetrix GeneChips as a tool for studying alternative forms of RNAAndrew P Harrison, Joanna Rowsell, Renata da Silva Camargo, et al.
Diabetes Research and Clinical Practice|December 23, 2008
Efficacy and safety of sitagliptin in the treatment of patients with type 2 diabetes in China, India, and KoreaViswanathan Mohan, Wenying Yang, Ho-Young Son, et al.
Pageof 9